Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Montelukast Sodium, and what generic Montelukast Sodium alternatives are available?

Montelukast Sodium is a drug marketed by Mylan Pharms Inc, Amneal Pharms, Kremers Urban Pharms, Teva Pharms, Dr Reddys Labs Ltd, Apotex Inc, Cspc Ouyi Pharm Co, Perrigo R And D, Sandoz Inc, Torrent Pharms Ltd, Accord Hlthcare, Glenmark Generics, Ajanta Pharma Ltd, West-ward Pharms Int, Unimark Remedies Ltd, Hetero Labs Ltd V, Cipla Ltd, Macleods Pharms Ltd, Aurobindo Pharma Ltd, Vintage Pharms Llc, Anbison Lab Co Ltd, Unichem Labs Ltd, Apotex Corp, and Jubilant Generics. and is included in forty-three NDAs.

The generic ingredient in MONTELUKAST SODIUM is montelukast sodium. There are thirty-two drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the montelukast sodium profile page.

Summary for Tradename: MONTELUKAST SODIUM

Suppliers / Packagers: see list54
Bulk Api Vendors: see list43
Clinical Trials: see list998
Patent Applications: see list1,914
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MONTELUKAST SODIUM at DailyMed

Pharmacology for Tradename: MONTELUKAST SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
montelukast sodium
TABLET, CHEWABLE;ORAL201581-002Aug 6, 2012ABRXNoNo► Subscribe► Subscribe
Teva Pharms
montelukast sodium
GRANULE;ORAL090955-001Aug 3, 2012ABRXNoNo► Subscribe► Subscribe
Vintage Pharms Llc
montelukast sodium
TABLET, CHEWABLE;ORAL091588-002Aug 3, 2012ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
montelukast sodium
TABLET, CHEWABLE;ORAL202096-002Aug 3, 2012ABRXNoNo► Subscribe► Subscribe
Anbison Lab Co Ltd
montelukast sodium
TABLET;ORAL205683-001Jan 12, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus